Beckman Coulter to Host 7th Annual Investor Meeting at the American Association for Clinical Chemistry -AACC-.

Business Editors

AACC 2002

Beckman Coulter, Inc. (NYSE:BEC) announced today it will host its 7th Annual Beckman Coulter Investor Meeting on Tuesday, July 30, 2002 at the American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo in Orlando, Florida. Attendees will have an opportunity to participate in two tours; first tour is of an Orlando area hospital laboratory followed by a tour of the Beckman Coulter booth in the exhibition hall. The tours will be hosted by John P. Wareham, chairman, president and chief executive officer, newly appointed president of the Clinical Diagnostics Division, Scott Garrett and Amin Khalifa, vice president finance and chief financial officer.

To receive full details, please contact Cynthia Skoglund, Investor Relations Senior Specialist, at 714/773-8213 or [e-mail].

The American Association for Clinical Chemistry (AACC) Annual Meeting & Clinical Lab Expo will begin on Monday, July 29 through Thursday, August 1, 2002 at the Orange County Convention Center in Orlando, Florida. AACC will host their annual IVD Industry Analyst Briefing on Monday afternoon, July 29, 2002. The AACC -- IVD Industry Exhibits will open on Tuesday, July 30 through Thursday, August 1, 2002. For more information visit: www.aacc.org.

Beckman Coulter, Inc. is a global biomedical company, headquartered in Fullerton, California. The company develops and markets instruments, chemistries, software and supplies that simplify and automate laboratory processes throughout the biomedical testing continuum. Through pioneering medical research and drug discovery, specialty testing, and patient care diagnostics, Beckman Coulter supports all phases of the battle against disease. Annual sales for the company totaled $2 billion in 2001, with 62% of this amount generated by recurring revenue from supplies, test kits and services. For more information, visit www.beckmancoulter.com.